// App-Quantinova.ai

396 : PIPE‐cloned human IgG4 antibodies inhibit activation of human basophils sensitized with IgE antibodies specific for the major milk allergen beta‐lactoglobulin in basophil activation tests (BAT)

Researchers

Presenter

  • Pranger CL

Principal Investigators

  • Singer JF

  • Khler VK

  • Pali-Schll I

  • Fiocchi A

  • Zenarruzabeitia O

  • Borrego F

  • Ilieva KM

  • Karagiannis SN

  • Jensen-Jarolim E

Medical Centers

  • The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria

  • Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectology and Immunology, Medical University Vienna, Vi- enna, Austria

  • Pediatric Hospital Bambino Gesù, Rome, Vatican City, Italy

  • Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain

  • Ikerbasque, Basque Foundation for Science, Bilbao, Spain

  • St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London & NIHR Biomedical Research Centre at Guy's and St. Thomas’ Hospital and King's College London, Guy's Hospital, King's College London, London, United Kingdom

  • Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom

Locations

  • Austria

  • Vatican City

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Immunoglobulin E

Drug/Treatment

  • IL-4

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A